Laboratory Tests for Bacterial Infections
Essential diagnostic methods for identifying bacterial skin infections through swabs, microscopy, culture, and advanced tests.

Skin swabs, pus, aspirates, biopsies and blood are taken for laboratory testing to establish or confirm the diagnosis of a bacterial infection of the skin.
Introduction
Bacterial infections of the skin and soft tissues are common dermatological concerns, often caused by pathogens such as Staphylococcus aureus or Streptococcus pyogenes. Accurate diagnosis is crucial due to rising antibiotic resistance and the need for targeted therapy. While clinical examination provides initial clues—such as erythema, warmth, swelling, and pus—laboratory tests confirm the causative organism and its susceptibility. These tests include specimen collection, direct microscopy, culture, blood analyses, and molecular methods. Early and precise identification prevents complications like cellulitis progression or sepsis.
Laboratory confirmation is especially vital when infections mimic other conditions like fungal or viral diseases, or in immunocompromised patients. Tests guide treatment, shifting from empirical broad-spectrum antibioticss to narrow-spectrum options based on sensitivities.
Specimen collection
Appropriate specimen collection is the cornerstone of accurate bacterial diagnosis. Poor technique can lead to contamination or false negatives, delaying effective treatment.
Common specimens include:
- Skin swabs: Ideal for superficial infections like impetigo or folliculitis. Swab purulent lesions, ulcers, or moist surfaces firmly for 5-10 seconds. Use sterile polyester or rayon swabs; avoid cotton due to inhibitors.
- Pus aspirates: For abscesses or deeper collections, lance and aspirate pus with a syringe for higher yield than swabs.
- Tissue biopsies: Punch biopsies from wound edges or debrided tissue provide definitive samples, especially in chronic or necrotic infections.
- Blood cultures: Essential for systemic spread, e.g., in cellulitis with fever or lymphadenopathy. Draw two sets from different sites before antibiotics.
Transport swabs in Amies or Stuart medium immediately to the lab at room temperature. For biopsies, use sterile containers. In wounds, clean debris first but avoid antiseptics that kill bacteria. Semi-quantitative reporting (light/moderate/heavy growth) helps distinguish infection (>105 CFU/g) from colonization.
Direct microscopy
Direct microscopy offers rapid preliminary results, often within hours, guiding initial therapy.
Primary method: Gram staining. Heat-fixed smears are stained with crystal violet, iodine, decolorized, and counterstained with safranin. Gram-positive bacteria (purple) include staphylococci (clusters) and streptococci (chains); Gram-negative (pink) like Pseudomonas suggest specific risks.
Key findings:
- Polymorphonuclear leukocytes (PMNs) with intracellular bacteria confirm active infection.
- Yeasts or hyphae prompt fungal tests.
- Absence of organisms doesn’t rule out infection if antibiotics were given prior.
Other stains: Acridine orange for fluorescing bacteria, or potassium hydroxide (KOH) to rule out fungi. In wounds, microscopy quantifies bacterial load and morphology, aiding urgency assessment. Limitations include low sensitivity in low-burden infections.
Culture
Bacterial culture remains the gold standard for identification and antibiotic susceptibility testing (AST), taking 24-48 hours.
Specimens are inoculated on selective media:
- Blood agar: For most aerobes/anaerobes; shows hemolysis (beta for Streptococcus).
- MacConkey agar: For Gram-negatives; lactose fermenters pink.
- Chocolate agar: For fastidious organisms like Haemophilus.
Incubate aerobically/anaerobically at 35-37°C. Identification uses biochemical tests, MALDI-TOF mass spectrometry for rapid species ID. AST via disk diffusion (Kirby-Bauer) or MIC determines susceptibility, critical amid MRSA rise.
Challenges:
- Contamination: Skin flora like coagulase-negative staphylococci.
- Prior antibiotics: Reduce yield.
- Colonization vs. infection: Heavy growth of pathogens with PMNs indicates true infection.
Culture identifies S. aureus, Group A Strep, and guides de-escalation.
Blood tests
Blood tests support diagnosis but are non-specific.
| Test | Purpose | Interpretation |
|---|---|---|
| Full blood count (FBC) | Leukocytosis | WCC >11×109/L, neutrophilia in bacterial infection. |
| C-reactive protein (CRP) | Inflammation marker | Elevated >10 mg/L; tracks response. |
| Procalcitonin | Bacterial vs. viral | >0.5 ng/mL suggests bacterial. |
| Erythrocyte sedimentation rate (ESR) | Non-specific inflammation | Elevated in severe cases. |
In cellulitis, CRP/FBC monitor severity; blood cultures positive in 5-20% bacteremic cases.
Molecular biology techniques
PCR and NAATs revolutionize diagnostics with speed (hours) and sensitivity, bypassing culture failures.
PCR: Amplifies bacterial DNA from swabs/biopsies. Multiplex panels detect 20+ pathogens simultaneously, including MRSA, VISA. Useful in antibiotics-pretreated patients.
Advantages: High sensitivity/specificity; quantifies load (Ct values).
Samples: Swabs, pus, tissue. Results guide therapy rapidly, especially in outbreaks.
Other: Next-gen sequencing for polymicrobial or unculturable bacteria.
Limitations: Costly; detects dead DNA; no routine AST.
Frequently Asked Questions (FAQs)
Q: When should I collect a swab for bacterial culture?
A: Swab purulent lesions before antibiotics. Clean superficial debris; transport promptly in Amies medium for best yield.
Q: What does a Gram stain show?
A: Bacterial morphology, Gram reaction, and PMNs. Gram-positive cocci in clusters suggest staphylococci; chains suggest streptococci.
Q: How long does culture take?
A: 24-48 hours for growth; AST adds 24 hours. Rapid ID via MALDI-TOF shortens to same day.
Q: Are blood tests sufficient for diagnosis?
A: No, they are supportive. Culture/microscopy confirm pathogen.
Q: What if culture is negative but infection suspected?
A: Consider PCR, repeat sampling, or biopsy. Prior antibiotics common cause.
Clinical Implications and Best Practices
Integrating tests optimizes outcomes. Empirical therapy for severe cases (e.g., IV flucloxacillin for cellulitis), then tailor. Monitor resistance patterns locally. In diabetic foot or surgical wounds, aggressive sampling prevents osteomyelitis. Multidisciplinary approach with microbiology input essential.
Patient education: Emphasize hygiene, complete antibiotics. Future: Point-of-care PCR for instant AST.
References
- Bacterial Skin Infections — DermNet NZ. 2024. https://dermnetnz.org/topics/bacterial-skin-infections
- Laboratory tests for viral infections — DermNet NZ. 2024. https://dermnetnz.org/topics/laboratory-tests-for-viral-infections
- Microbiological assessment of infected wounds — bpac.org.nz. 2013-06-01. https://bpac.org.nz/bt/2013/june/infected-wounds.aspx
- Cellulitis — Better Health Channel (Vic.gov.au). 2024. https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/cellulitis
- Cellulitis – StatPearls — NCBI Bookshelf (NIH). 2023-10-27. https://www.ncbi.nlm.nih.gov/books/NBK549770/
Read full bio of medha deb














